Mortality Risk in IgA Nephropathy.

IgA nephropathy (IgAN) is a common form of primary GN known to affect about 200,000–350,000 persons per year globally,[1][1] most frequently in Asia and least frequently in Africa.[2][2] Presently, the diagnosis of IgAN is established only by kidney biopsy and immunofluorescence microscopy;